In addition, tau phosphorylated at residue 181 (p-tau181) was also analyzed by immunodetection, confirming the higher levels of this common marker of AD in patients with DAT, both with and without CVD (Fig. 3D). The gene discussed is MAPT; the disease is Alzheimer disease.